Global Hemostats Market Worth USD 4.5 Billion by 2024
Global Hemostats Market, By Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Application (Wound Closure, Surgery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)
The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Major Players: Global Hemostats Market
Some of the major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt and Equimedical, B.V. among other companies.
Ask for Sample Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
Drivers: Global Hemostats Market
Some of the major factors driving the hemostats market are increasing number of minimally invasive surgeries, chronic conditions and aging population leading to increase in number of surgical procedures, expansion in healthcare infrastructure and expenditure, and technological advancements. These factors increase the demand for hemostats such as thrombin based haemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based hemostats and collagen based haemostats.
CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES
Hemostats are vital in any surgical process or acts as a foundational component of healthcare systems. Growing geriatric population has resulted in increase in cases of acute and chronic diseases. Older population is more prone to diseases such as diabetes, infections, cardiometabolic risks and cancer leading to more number of surgeries, which is driving the growth of the hemostats market.
The key players are investing in development of safe and efficacious agents to meet surgical demand as more minimally invasive and technically challenging operations are being undertaken by surgeons. Advances in hemostatic agents and techniques are manufactured which addresses the unique bleeding challenges encountered in vascular surgery patients.
INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES
An increasing trend of minimally invasive surgeries is witnessed due various advantages compared to open surgeries such as less post-operative pain, reduced trauma to the skin and muscles, and quick recovery. The surgical toolbox is expanding, and newer products are being developed to improve results of the surgeries. Less invasive procedures result in shorter recovery times, faster discharges, reduced scarring, pain and the need for pain medications.
Browse Full Report Visit: http://databridgemarketresearch.com/reports/global-hemostats-market/
The global hemostats market is highly concentrated market with major key players and local players to cater the domestic market. Ethicon US LLC dominated the hemostats market accounting for the highest market share in 2016, followed by Pfizer Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global hemostats market in 2016.
ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.
1. In June, 2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable hemostat. This hemostat powder will help surgeons to have a simple and predictable adjunctive hemostatic solution to control continuous oozing on broad or raw surfaces.
2. In August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve patient’s condition through Ethicon surgical products.
Inquiry for TOC Visit: http://databridgemarketresearch.com/toc/?dbmr=global-hemostats-market
Global Medical Device Reprocessing Market – Industry Trends and Forecast to 2024
Global Medical Device Reprocessing Market By Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection); Type (Enzymatic & Non-enzymatic Detergent); Application (Surgical Instruments, Endoscope, Ultrasound Probe);End User (Hospitals, Clinics, Diagnostic Centers); Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)
Report Access: http://databridgemarketresearch.com/reports/global-medical-device-reprocessing-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hemostats Market Worth USD 4.5 Billion by 2024 here
News-ID: 705719 • Views: 188
More Releases from Data Bridge Market Research
Tangerine Essential Oil Market Booming at a CAGR of 3.65% by 2026 with Top Key P …
The tangerine oil helps in supporting the metabolism and healthy digestion. Tangerine has a tangy and sweet aroma similar to the citrus oils. Tangerine oil is known for their cleansing properties and also for supporting the healthy respiratory and immune system. This essential oil can also be used for soothing anxious feelings and managing stress. It can also be used in any recipe specifically for citrus fruits. Global Tangerine Essential Oil
Blinds and Shades Market to Grow at a Healthy CAGR by 2026 with Top Company Anal …
Blinds and shades main function is to cover windows and is a part of the hard window coverings. They filter the light and provide privacy. Roller shades, panel blinds, roam shades/ blinds, honeycomb shades; pleated shades and other are some of the common types of the blinds and shades. They are either made of synthetic or natural fabrics and are used in residential and commercial purposes. These blinds and shades
Notoginseng Root Extract Market Analysis, Segments, Value Share, Top Company Ana …
Notoginseng is an herb mainly used for blood and circulation associated conditions. Notoginseng can be often used together with various other herbs for stopping both external and internal bleeding, It is also provided to support other effects including anti-inflammatory, immunostimulatory, anti-fibrotic, neuroprotective and others. There is increasing evidence that notoginseng has both anti-haemostatic and pro-haemostatic properties. Market Analysis: Global Notoginseng Root Extract Market Global Notoginseng Root Extract Market is expected to register
Global data center construction market Business Development Strategies 2019: Key …
This data center construction market report is the most suitable solution for your business requirements in many ways. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s Five Forces analysis. Nowadays, businesses are highly relying on the different segments covered in the market research report which presents better insights to drive the business into right direction. The examination is planned for giving readers
More Releases for Hemostat
Europe Hemostat Powder Market Develop business strategies
MarketResearchReports.Biz adds “Europe Hemostat Powder Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Hemostat Powder and the growth estimates for the forecasted period. When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence,
India Hemostat Market: Regional Outlook and Forecast 2016–2025
Demand for hemostats in India will be worth 56.7 Mn in 2016, up from US$ 54.1 Mn in 2015. Growth will be led by steady demand for mechanical hemostats, such as sponges, gauzes, strips, and films. Mechanical hemostats will account for 88.4% revenue share of the market in 2016. Adoption of hemostats that reduce post-operative time and increase in complex surgeries will continue to create sustained demand for hemostats. Rising
Global Hemostat Market 2017 - YDM, HOYA, Daji, Angel
Apex Market Reports, recently published a detailed market research study focused on the "Hemostat Market" across the global, regional and country level. The report provides 360° analysis of "Hemostat Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Hemostat industry, and estimates the future trend of Hemostat market on the basis of
Hemostat – Global Market Outlook (2016-2022)
The report on global Hemostat market portrays comprehensive information and conducts a complete study to provide latest market updates and information about present and forecast market scenario. The changes taking place in Hemostat are elaborated in this report to help readers in making vital business decisions. The Hemostat industry details are provided in the form of graphs, pie-charts to help the emerging and existing market players, buyers, and suppliers in
24Life Sciences: Global Hemostat Powders Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hemostat Powders for these regions, from 2012 to 2022 (forecast), covering, • United States • China • Europe • Japan • Southeast Asia • India Global Hemostat Powders market competition by top manufacturers/players, with Hemostat Powders sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including, • Pfizer • Ethicon • C. R. Bard • Gelita Medical • Equimedical • Biocer • Celox • Hemostasis • MBP • Medira • Hemotec Medical • Starch Medical • Success Pharmaceutical • Changsha Hairun Get Free
Global Hemostat Powders Industry 2017:Demand ,Overview and Analysis 2022
Summary Orbis Research delivers key insights on the Global Hemodialysis Powder Solution market in a new report titled “2017 Market Research Report on Global Hemostat Powders Industry.” In this report, Orbis Research sheds light on the various factors and trends impacting market growth over the forecast period (2017 – 2022). Description In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new